Ask AI
ProCE Banner Activity

Interactive Tool to Guide the Management of BTK Inhibitor–Related Adverse Events in MCL

Tool

Use this Interactive Decision Support Tool to get expert recommendations on managing adverse events associated with BTK inhibitors when treating MCL.

Released: April 27, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

This activity is intended for hematology/oncology physician specialists and other healthcare professionals providing care for patients with mantle cell lymphoma in the United States.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select optimal treatments for patients with treatment-naive MCL, considering expert recommendations along with available efficacy and safety evidence

  • Identify patients with MCL most likely to benefit from chemotherapy-free treatment options

  • Plan therapeutic strategies for patients with relapsed/refractory MCL based on the clinical evidence and expert guidance on current and emerging treatment options

Disclosure

Primary Author

Brad Kahl, MD: consultant/advisor/speaker: AbbVie, AstraZeneca, BeOne, Genentech, Incyte, Lilly, Merck, Pfizer, Roche.

Kami Maddocks, MD: consultant/advisor/speaker: AbbVie, ADC Therapeutics, AstraZeneca, Autolous, Bristol Myers Squibb, Caribou, Genentech, Genmab, Incyte, Lilly.

Javier Munoz, MD, MS, MBA, FACP: consultant: ADC Therapeutics, Alexion, AstraZeneca, Aurobindo, Bayer, BeiGene, Celgene/Bristol Myers Squibb, Epizyme, Fosun/Kite, Genentech/Roche, Genmab, Genzyme, Gilead/Kite, Janssen, Karyopharm, Kyowa, Lilly, MEI, MorphoSys/Incyte, Novartis, Pfizer, Pharmacyclics/AbbVie, Seattle Genetics, TG Therapeutics, Verastem; research funding: Bayer, BeiGene, Celgene, E.R. Squibb & Sons, Genentech, Gilead/Kite, Incyte, Janssen, Merck, Millennium, Novartis, Pharmacyclics, Portola, Seattle Genetics; honoraria: Aptitude Health, Curio, OncView, Targeted Oncology.

Tycel J. Phillips, MD: advisory board: AbbVie, ADCT, BeiGene, Celgene/Bristol Myers Squibb, Genentech, Genmab, Lilly, Merck, Pharmacyclics, Seattle Genetics/Pfizer, Xencor; researcher: AbbVie, ADC, Bristol Myers Squibb, Genentech, Sobi; consultant: AbbVie, AstraZeneca, Bristol Myers Squibb, Caribou, Genentech, Gilead/Kite, Incyte, Ipsen, Janssen, Johnson & Johnson, Pfizer, Xencor.

Julie M. Vose, MD, MBA: consultant/advisor/speaker: AbbVie, Ascentage, BeOne, Genentech, GenMab, Kyowa Kirin.